Author: Philip Davis

Note: The way each portfolio works is that I have what I call a rotating $3000 starting portfolio that is broken into three smaller $1000 accounts. This way I can account for cash settlement time but still play the market on...

Yeah for Bernanke! Sorry about the lateness of my post today. I recently made a big move to Central Time, and I am getting a little adjusted to the time difference. Anyways, let us get into the thick of it. Bernanke getting...

Word is our Fed Chairman will be reappointed this morning. This is good news for the markets,who hate uncertainty and settling this matter well ahead of Ben’s Jan expiration date and I agree with Calculated Risk’s...

Monday markets as Phil has pointed out in his post, the market looks to continue its momentum from last week into Monday as the Asian and European markets have done thus far today. The question though is can that momentum carry...

What a wild ride! To think the S&P 500 was at 666 back in March and here we are, less than 6 months later with the S&P finishing last week at 1,026 (up 54%), just a point off Friday’s high and up at levels we...

OK then, we’re off! I’m not sure how things will work with Wall Street Survivor yet, that will be the first alert we send out! Meanwhile, keep in mind that this is a virtual portfolio and your personal investment...

I recently went down to Florida to see my folks and found something disturbing as I talked to their friends. We all know that many people who have been on fixed incomes lost 50% of more of their portfolios during the crash but...

This is oursecond installment of Pharmboy’s Phavorites. Our original post ran on August 8th, when we went long in a series of very timely calls on GSK, with a $33.93/34.37 buy/write (GSK up 3% so far); AZN was our bear...